The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	17.85B -28.2%
Revenue (ttm)	14.70B -4.0%
Net Income	2.32B -21.6%
EPS	1.23 -24.4%
Shares Out	1.97B
PE Ratio	7.35
Forward PE	10.57
Dividend	0.48 (5.19%)
Ex-Dividend Date	Jul 7, 2026

Volume	3,760,000
Average Volume	5,620,558
Open	9.03
Previous Close	9.05
Day's Range	8.98 - 9.32
52-Week Range	8.96 - 17.98
Beta	0.35
RSI	32.57
Earnings Date	May 28, 2026

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,400
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2025, HKG:3933's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY